Otsuka (OTCMKTS:OTSKF – Get Free Report) is expected to be releasing its resultson Friday, July 31st. Analysts expect Otsuka to announce earnings of $1.01 per share and revenue of $3.9382 billion for the quarter.
Otsuka Stock Performance
OTSKF opened at $66.50 on Wednesday. The stock has a fifty day simple moving average of $65.25 and a two-hundred day simple moving average of $65.20. Otsuka has a 12-month low of $54.26 and a 12-month high of $72.22.
About Otsuka
Otsuka Holdings Co, Ltd., trading on OTC markets as OTSKF, is a global healthcare company headquartered in Tokyo, Japan. Established in 1964 as a research-driven pharmaceutical firm, Otsuka has since evolved into a diversified holding company overseeing operations in pharmaceuticals, nutraceuticals and consumer products. The company operates through a network of subsidiaries, including Otsuka Pharmaceutical Co, Ltd., Otsuka America Pharmaceutical, Inc, and Otsuka Europe, each focusing on drug development, manufacturing and distribution.
In its pharmaceutical division, Otsuka is best known for discovering and commercializing treatments in areas such as psychiatry, oncology and nephrology.
Recommended Stories
- Five stocks we like better than Otsuka
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
